Deletion of the Entire Interferon-γ Receptor 1 Gene Causing Complete Deficiency in Three Related Patients

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 2016 Mar 3

PMID 26931784

Citations 11

Authors

Inge C de Vor

Pomme M van der Meulen

Vincent Bekker

Els M Verhard

Martijn H Breuning

Esther Harnisch

Maarten J D Van Tol

Jantien W Wieringa

Esther van de Vosse

Robbert G M Bredius

Affiliations

Soon will be listed here.

Abstract

Purpose: Complete interferon-γ receptor 1 (IFN-γR1) deficiency is a primary immunodeficiency causing predisposition to severe infection due to intracellular pathogens. Only 36 cases have been reported worldwide. The purpose of this article is to describe a large novel deletion found in 3 related cases, which resulted in the complete removal of the IFNGR1 gene.

Methods: Whole blood from three patients was stimulated with lipopolysaccharide (LPS) and IFN-γ to determine production of tumor necrosis factor (TNF), interleukin-12 p40 (IL-12p40) and IL-10. Expression of IFN-γR1 on the cell membrane of patients' monocytes was assessed using flow cytometry. IFNGR1 transcript was analyzed in RNA and the gene and adjacent regions were analyzed in DNA. Finally, IL22RA2 transcript levels were analyzed in whole blood cells and dendritic cells.

Results: There was no expression of the IFN-γR1 on the monocytes. Consistent with this finding, there was no IFN-γ response in the whole blood assay as measured by effect on LPS-induced IL-12p40, TNF and IL-10 production. A 119.227 nt homozygous deletion on chromosome 6q23.3 was identified, removing the IFNGR1 gene completely and ending 117 nt upstream of the transcription start of the IL22RA2 gene. Transcript levels of IL22RA2 were similar in patient and control.

Conclusions: We identified the first large genomic deletion of IFNGR1 causing complete IFN-γR1 deficiency. Despite the deletion ending very close to the IL22RA2 gene, it does not appear to affect IL22RA2 transcription and, therefore, may not have any additional clinical consequence.

Citing Articles

A Novel Combination of Compound Heterozygous Variants in IFNGR1 Causing Complete IFNGR1 Deficiency.

LaBere B, Christian E, Kapadia M, Prockop S, McDonald D, Johnston A J Clin Immunol. 2024; 44(5):111.

PMID: 38676746 DOI: 10.1007/s10875-024-01716-7.

Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression.

Tecalco-Cruz A, Medina-Abreu K, Oropeza-Martinez E, Zepeda-Cervantes J, Vazquez-Macias A, Macias-Silva M World J Clin Oncol. 2024; 15(2):195-207.

PMID: 38455133 PMC: 10915940. DOI: 10.5306/wjco.v15.i2.195.

Adult-onset Mendelian Susceptibility to Mycobacterial Diseases: A case report and systematic literature review.

Yang Y, Xia L, Lu S Heliyon. 2023; 9(12):e22632.

PMID: 38058431 PMC: 10696185. DOI: 10.1016/j.heliyon.2023.e22632.

Disseminated Infection in a Child with Complete Interferon-γ Receptor 1 Deficiency due to Compound Heterozygosis of for a Subpolymorphic Copy Number Variation and a Novel Splice-Site Variant.

Bossi G, Errichiello E, Zuffardi O, Marone P, Monzillo V, Barbarini D J Pediatr Genet. 2020; 9(3):186-192.

PMID: 32714620 PMC: 7375849. DOI: 10.1055/s-0039-1700803.

LINE-1-Mediated AluYa5 Insertion Underlying Complete Autosomal Recessive IFN-γR1 Deficiency.

Rosain J, Deswarte C, Hancioglu G, Oleaga-Quintas C, Kutlug S, Kartal I J Clin Immunol. 2019; 39(7):739-742.

PMID: 31377971 PMC: 8165577. DOI: 10.1007/s10875-019-00667-8.

References

Noordzij J, Hartwig N, Verreck F, de Bruin-Versteeg S, de Boer T, van Dissel J . Two patients with complete defects in interferon gamma receptor-dependent signaling. J Clin Immunol. 2007; 27(5):490-6. DOI: 10.1007/s10875-007-9097-8. View

Bax H, Freeman A, Ding L, Hsu A, Marciano B, Kristosturyan E . Interferon alpha treatment of patients with impaired interferon gamma signaling. J Clin Immunol. 2013; 33(5):991-1001. PMC: 4136390. DOI: 10.1007/s10875-013-9882-5. View

Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W . Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol. 1999; 27(9):1368-74. DOI: 10.1016/s0301-472x(99)00077-6. View

Rosenzweig S, Dorman S, Roesler J, Palacios J, Zelazko M, Holland S . 561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain. Clin Immunol. 2002; 102(1):25-7. DOI: 10.1006/clim.2001.5135. View

Martin J, Beriou G, Heslan M, Chauvin C, Utriainen L, Aumeunier A . Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol. 2013; 7(1):101-13. PMC: 4291114. DOI: 10.1038/mi.2013.28. View

Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J, Newport M . Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996; 335(26):1956-61. DOI: 10.1056/NEJM199612263352604. View

Cunningham J, Kellner J, Bridge P, Trevenen C, McLeod D, Davies H . Disseminated bacille Calmette-Guérin infection in an infant with a novel deletion in the interferon-gamma receptor gene. Int J Tuberc Lung Dis. 2000; 4(8):791-4. View

Horwitz M, Uzel G, Linton G, Miller J, Brown M, Malech H . Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency. Blood. 2003; 102(7):2692-4. DOI: 10.1182/blood-2003-04-1268. View

Hartwig N, Warris A, van de Vosse E, van der Zanden A, Schulin-Casonato T, van Ingen J . "Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis. J Clin Microbiol. 2011; 49(12):4409-11. PMC: 3233006. DOI: 10.1128/JCM.05460-11. View

10.

Bustamante J, Boisson-Dupuis S, Abel L, Casanova J . Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014; 26(6):454-70. PMC: 4357480. DOI: 10.1016/j.smim.2014.09.008. View

11.

Camcioglu Y, Picard C, Lacoste V, Dupuis S, Akcakaya N, Cokura H . HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr. 2004; 144(4):519-23. DOI: 10.1016/j.jpeds.2003.11.012. View

12.

Jouanguy E, Dupuis S, Pallier A, Doffinger R, Fondaneche M, Fieschi C . In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest. 2000; 105(10):1429-36. PMC: 315467. DOI: 10.1172/JCI9166. View

13.

Kotenko S, Izotova L, Mirochnitchenko O, Esterova E, Dickensheets H, Donnelly R . Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol. 2001; 166(12):7096-103. DOI: 10.4049/jimmunol.166.12.7096. View

14.

Ward C, Jyonouchi H, Kotenko S, Smirnov S, Patel R, Aguila H . Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Eur J Pediatr. 2006; 166(9):981-5. DOI: 10.1007/s00431-006-0339-1. View

15.

van de Wetering D, de Paus R, van Dissel J, van de Vosse E . Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1. Mol Immunol. 2009; 47(5):1023-30. DOI: 10.1016/j.molimm.2009.11.016. View

16.

Taramasso L, Boisson-Dupuis S, Garre M, Bondi E, Cama A, Nozza P . Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review. J Clin Immunol. 2014; 34(8):922-7. DOI: 10.1007/s10875-014-0098-0. View

17.

Quispel W, Stegehuis-Kamp J, Santos S, van Wengen A, Dompeling E, Egeler R . Intact IFN-γR1 expression and function distinguishes Langerhans cell histiocytosis from mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2013; 34(1):84-93. DOI: 10.1007/s10875-013-9959-1. View

18.

Levin M, Newport M, DSouza S, Kalabalikis P, BROWN I, Lenicker H . Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?. Lancet. 1995; 345(8942):79-83. DOI: 10.1016/s0140-6736(95)90059-4. View

19.

Wang Q, Xia W, Zhao D . [Interferon-gamma receptor 1 deficiency in a 19-month-old child: case report and literature review]. Zhonghua Er Ke Za Zhi. 2014; 52(5):387-91. View

20.

de Groot R, van Dongen J, Neijens H, Hooijkaas H, Drexhage H . Familial disseminated atypical mycobacterial infection in childhood. Lancet. 1995; 345(8955):993. DOI: 10.1016/s0140-6736(95)90744-0. View